Sigal Charles Elliott has filed 13 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 16000 shares of Vir Biotechnology, Inc. ($VIR) on May 30, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 137,143,286 | 9999.99% | 0.01% |
| May 30, 2025 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Common Stock | 8000 | $0.00 | 41,806.0000 | 137,143,286 | 23.66% | 0.01% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Sigal Charles Elliott | Director | A | Stock Option (right to buy) | 1558 | $0.00 | 1,558.0000 | 127,651,000 | 9999.99% | 0.00% |
| May 8, 2025 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Sigal Charles Elliott | Director | A | Common Stock | 775 | $0.00 | 2,775.0000 | 127,651,000 | 38.75% | 0.00% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Stock Option (Right to Buy) | 16000 | $0.00 | 16,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Common Stock | 8000 | $0.00 | 33,806.0000 | 0 | 31.00% | 0.00% |
| May 16, 2024 | ALNYLAM PHARMACEUTICALS, INC. | $ALNY | Sigal Charles Elliott | Director | A | Stock Option (right to buy) | 5228 | $0.00 | 5,228.0000 | 124,906,000 | 9999.99% | 0.00% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Common Stock | 6027 | $0.00 | 25,806.0000 | 0 | 30.47% | 0.00% |
| May 22, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | A | Stock Option (Right to Buy) | 12054 | $0.00 | 12,054.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | P | Common Stock | 2500 | $22.73 | 19,779.0000 | 0 | 14.47% | 0.00% |
| Jan. 5, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | P | Common Stock | 2500 | $24.96 | 17,279.0000 | 0 | 16.92% | 0.00% |
| Jan. 3, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | P | Common Stock | 2500 | $25.60 | 12,279.0000 | 0 | 25.56% | 0.00% |
| Jan. 4, 2023 | Vir Biotechnology, Inc. | $VIR | Sigal Charles Elliott | Director | P | Common Stock | 2500 | $25.25 | 14,779.0000 | 0 | 20.36% | 0.00% |